Immunovant, Inc. (IMVT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 0 | 101K | 105K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 0 | -101K | -105K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 159.55M | 114.36M | 131.76M | 127.22M | 113.83M | 114.3M | 115.74M | 94.28M | 80.88M | 61.55M | 61.8M | 65.98M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 17.27M | 15.44M | 17.51M | 26.02M | 20.17M | 19.78M | 18.47M | 18.81M | 14.82M | 13.21M | 13.84M | 15.4M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 142.29M | 98.92M | 114.25M | 101.2M | 93.65M | 94.52M | 97.27M | 75.47M | 66.06M | 48.34M | 47.96M | 50.58M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -159.55M | -114.36M | -131.76M | -127.22M | -113.83M | -114.3M | -115.74M | -94.28M | -80.88M | -61.55M | -61.8M | -65.98M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -40.17% | -0.05% | -13.84% | -34.94% | -40.73% | -85.7% | -87.29% | -42.9% | -25.86% | -13.93% | -24.56% | -63.41% |
| EBITDA | -159.46M | -114.26M | -131.66M | -127.12M | -113.72M | -114.2M | -115.65M | -94.2M | -80.81M | -61.49M | -61.74M | -65.92M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -40.22% | -0.05% | -13.84% | -34.94% | -40.71% | -85.71% | -87.31% | -42.89% | -25.87% | -13.93% | -24.56% | -63.46% |
| D&A (Non-Cash Add-back) | 96K | 101K | 105K | 107K | 109K | 99K | 89K | 80K | 64K | 58K | 56K | 53K |
| EBIT | -159.55M | -109.08M | -131.76M | -127.22M | -113.83M | -114.3M | -115.74M | -94.28M | -80.88M | -61.55M | -61.8M | -65.98M |
| Net Interest Income | 8.06M | 5.33M | 5.6M | 6.34M | 6.89M | 4.59M | 6.07M | 7.18M | 8.38M | 8.93M | 3.57M | 4.07M |
| Interest Income | 8.06M | 5.33M | 5.6M | 6.34M | 6.89M | 4.59M | 6.07M | 7.18M | 8.38M | 8.93M | 3.57M | 4.07M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 8.85M | 5.28M | 5.85M | 7.52M | 7.96M | 3.33M | 6.7M | 7.21M | 5.79M | 10.03M | 3.59M | -7.97M |
| Pretax Income | -150.7M | -109.08M | -125.91M | -119.7M | -105.87M | -110.97M | -109.04M | -87.07M | -75.09M | -51.53M | -58.21M | -73.95M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | -2.84M | 1.55M | 594K | 913K | 583K | 152K | 78K | 77K | 232K | -108K | 454K | -11K |
| Effective Tax Rate % | 1.89% | -1.42% | -0.47% | -0.76% | -0.55% | -0.14% | -0.07% | -0.09% | -0.31% | 0.21% | -0.78% | 0.01% |
| Net Income | -147.86M | -110.64M | -126.5M | -120.61M | -106.45M | -111.12M | -109.12M | -87.15M | -75.32M | -51.42M | -58.66M | -73.94M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -38.9% | 0.44% | -15.93% | -38.4% | -41.33% | -116.11% | -86.01% | -17.87% | -26.73% | 18.68% | -22.4% | -83.13% |
| Net Income (Continuing) | -147.86M | -110.64M | -126.5M | -120.61M | -106.45M | -111.12M | -109.12M | -87.15M | -75.32M | -51.42M | -58.66M | -73.94M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.73 | -0.61 | -0.73 | -0.71 | -0.64 | -0.76 | -0.74 | -0.60 | -0.52 | -0.36 | -0.45 | -0.57 |
| EPS Growth % | -14.06% | 19.74% | 1.35% | -18.33% | -23.08% | -111.11% | -64.44% | -5.26% | -13.04% | 26.53% | -9.76% | -62.86% |
| EPS (Basic) | -0.73 | -0.61 | -0.73 | -0.71 | -0.64 | -0.76 | -0.74 | -0.60 | -0.52 | -0.36 | -0.45 | -0.57 |
| Diluted Shares Outstanding | 203.71M | 181.51M | 173.64M | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M |
| Basic Shares Outstanding | 203.71M | 181.51M | 173.64M | 170.87M | 151.57M | 146.92M | 146.47M | 146.09M | 145.36M | 144.52M | 131.16M | 130.5M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |